Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic commonly causes nausea, vomiting, diarrhoea, and constipation. However, in non-diabetics using it for weight loss, these symptoms can be more pronounced. The delayed gastric emptying ...

Ozempic is primarily used for managing type 2 diabetes, whereas Wegovy is specifically approved for weight loss. Who is it for? Wegovy is approved for adults with a body mass index (BMI ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...